Biosimilars in osteoporosis treatment: focus on denosumab

Aapro, M., Hadji, P., Santini, D. et al. (2 more authors) (2025) Biosimilars in osteoporosis treatment: focus on denosumab. Expert Opinion on Biological Therapy. ISSN: 1471-2598

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2025 The Authors. Except as otherwise noted, this author-accepted version of a journal article published in Expert Opinion on Biological Therapy is made available via the University of Sheffield Research Publications and Copyright Policy under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/

Keywords: Biosimilar; bone loss; denosumab; multidisciplinary; osteoporosis; patient education; undertreatment
Dates:
  • Submitted: 14 May 2025
  • Accepted: 24 July 2025
  • Published (online): 28 July 2025
  • Published: 28 July 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 31 Jul 2025 14:40
Last Modified: 01 Aug 2025 14:02
Status: Published online
Publisher: Taylor and Francis Group
Refereed: Yes
Identification Number: 10.1080/14712598.2025.2540471
Open Archives Initiative ID (OAI ID):

Export

Statistics